Jörn Schattenberg, Louise Campbell and Roger Green wrap up the discussion of NASH drug development in 2022 by citing their reasons for optimism, ranging from what researchers have proven already about safety and efficacy to the likelihood that combination therapy will eventually become the core therapeutic strategy and the emerging importance of quality of life measures.
Stephen Harrison, Jörn Schattenberg, Louise Campbell and Roger Green all discuss the role that combination NASH drugs and greater population diversity in clinical trials will strengthen NASH drug development.
The discussion of drugs in development continues, with specific focus on the treasure trove of data Intercept is producing for OCA and why combination therapy will probably be critical element in the long-term treatment strategy for NASH.
Stephen Harrison discusses the state of NASH Drug Development in 2022 with focus on the key steps on the pathway and how late-stage NASH drugs are progressing
Stephen Harrison leads a review of drug development and where we are in the NASH pipeline as Jörn Schattenberg, Louise Campbell and Roger Green lend their own perspectives and ask questions
On May 6 and 7, over 100 NAFLD stakeholders convened in Barcelona and online for the inaugural Innovations in NAFLD Care 2022 conference (#INCBCN.)
Co-chair Jeff Lazarus joins the Surfers (including co-chair Jörn Schattenberg) to review last week’s Innovations in NAFLD Care 2022 conference PLUS Roger Green interviews one of the events’ speakers, Human Edge CEO Dr. Marcus Ranney
Patient advocates Achim Kautz and Andrew Scott join the Surfers to discuss value of NAFLD patient advocacy in the Fatty Liver community. This conversation focuses on whether there is an actual integrated community along with key areas to build successes.
Achim Kautz and Andrew Scott discuss some of their successes in patient advocacy, while Louise Campbell raises a question about which patients should be the focus of advocates’ activities.
Patient advocates Andrew Scott from the Global Liver Institute and Achim Kautz from Germany share their backgrounds, perspective, goals, and strategies with the Surfers.
